发明名称 |
COMBINATION OF ORGANIC COMPOUNDS |
摘要 |
The invention relates to a combination of at least two therapeutic combination components selected from the group consisting of (i) an AT1-receptor antagonist or an AT1 receptor antagonist combined with a diuretic or, in each case, a pharmaceutically acceptable salt thereof, (ii) a HMG-Co-A reductase inhibitor or a pharmaceutically acceptable salt thereof and (iii) an ACE inhibitor or a pharmaceutically acceptable salt thereof for use in the prevention of, delay of progression of, treatment of selected diseases and conditions.
|
申请公布号 |
WO0176573(A2) |
申请公布日期 |
2001.10.18 |
申请号 |
WO2001EP04115 |
申请日期 |
2001.04.10 |
申请人 |
NOVARTIS AG;NOVARTIS-ERFINDUNGEN;DE GASPARO, MARC;GRAVES, KURT, C. |
发明人 |
DE GASPARO, MARC;GRAVES, KURT, C. |
分类号 |
A61K45/06;A61K31/22;A61K31/351;A61K31/40;A61K31/401;A61K31/4045;A61K31/41;A61K31/4178;A61K31/4184;A61K31/4196;A61K31/437;A61K31/4418;A61K31/4439;A61K31/4709;A61K31/522;A61K31/55;A61K31/551;A61K31/675;A61K38/00;A61K38/55;A61P3/04;A61P3/06;A61P3/10;A61P5/14;A61P7/10;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P13/12;A61P15/10;A61P43/00;(IPC1-7):A61K31/00 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|